AT360671B - Verfahren zur herstellung von neuen thienyl- -prostaglandinen, ihren salzen und estern - Google Patents

Verfahren zur herstellung von neuen thienyl- -prostaglandinen, ihren salzen und estern

Info

Publication number
AT360671B
AT360671B AT413676A AT413676A AT360671B AT 360671 B AT360671 B AT 360671B AT 413676 A AT413676 A AT 413676A AT 413676 A AT413676 A AT 413676A AT 360671 B AT360671 B AT 360671B
Authority
AT
Austria
Prior art keywords
prostaglandines
esters
salts
producing new
thienyl
Prior art date
Application number
AT413676A
Other languages
German (de)
English (en)
Other versions
ATA413676A (de
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ATA413676A publication Critical patent/ATA413676A/de
Application granted granted Critical
Publication of AT360671B publication Critical patent/AT360671B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/32Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09JADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J7/00Adhesives in the form of films or foils
    • C09J7/10Adhesives in the form of films or foils without carriers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT413676A 1975-06-05 1976-06-04 Verfahren zur herstellung von neuen thienyl- -prostaglandinen, ihren salzen und estern AT360671B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2524955A DE2524955C3 (de) 1975-06-05 1975-06-05 Neue Thienyl-Prostaglandine und Verfahren zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
ATA413676A ATA413676A (de) 1980-06-15
AT360671B true AT360671B (de) 1981-01-26

Family

ID=5948288

Family Applications (1)

Application Number Title Priority Date Filing Date
AT413676A AT360671B (de) 1975-06-05 1976-06-04 Verfahren zur herstellung von neuen thienyl- -prostaglandinen, ihren salzen und estern

Country Status (20)

Country Link
US (1) US4258053A (en, 2012)
JP (3) JPS527954A (en, 2012)
AT (1) AT360671B (en, 2012)
AU (1) AU517489B2 (en, 2012)
BE (1) BE842687A (en, 2012)
CA (1) CA1086722A (en, 2012)
CH (1) CH625213A5 (en, 2012)
DE (1) DE2524955C3 (en, 2012)
DK (1) DK152675C (en, 2012)
ES (1) ES448387A1 (en, 2012)
FR (1) FR2313036A1 (en, 2012)
GB (1) GB1553914A (en, 2012)
HU (1) HU175238B (en, 2012)
IE (1) IE43849B1 (en, 2012)
IL (1) IL49716A (en, 2012)
IT (1) IT1061525B (en, 2012)
LU (1) LU75076A1 (en, 2012)
MX (1) MX3609E (en, 2012)
NL (1) NL188693C (en, 2012)
SE (2) SE430158B (en, 2012)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04107991U (ja) * 1991-02-26 1992-09-17 テーダブリユ電気株式会社 ヘツドホン
WO2016153094A1 (ko) * 2015-03-26 2016-09-29 비스메르 주식회사 3-알콕시싸이오펜 유도체의 신규한 제조방법
CN106146455A (zh) * 2015-03-30 2016-11-23 维斯曼株式会社 3-烷氧基噻吩衍生物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956284A (en) * 1972-07-13 1976-05-11 Pfizer Inc. Heterocyclic 15-substituted-ω-pentanorprostoglandins
GB1428137A (en) * 1972-09-27 1976-03-17 Ici Ltd Prostanoic acid derivatives
GB1431561A (en) * 1973-01-31 1976-04-07 Ici Ltd Cyclopentane derivatives
US3931279A (en) * 1973-05-21 1976-01-06 The Upjohn Company 5-Oxa prostaglandin F2.sub.α analogs
US3932289A (en) * 1973-11-09 1976-01-13 Chevron Research Company Preparation of overbased carbonated sulfurized magnesium alkylphenates
GB1484591A (en) * 1974-04-11 1977-09-01 Ono Pharmaceutical Co Prostaglandin compositions

Also Published As

Publication number Publication date
DK248176A (da) 1976-12-06
SE430158B (sv) 1983-10-24
BE842687A (fr) 1976-12-08
IL49716A (en) 1980-10-26
JPS61243075A (ja) 1986-10-29
DE2524955B2 (de) 1981-02-12
IT1061525B (it) 1983-04-30
DE2524955A1 (de) 1977-03-17
GB1553914A (en) 1979-10-10
ES448387A1 (es) 1977-08-01
HU175238B (hu) 1980-06-28
CA1086722A (en) 1980-09-30
CH625213A5 (en, 2012) 1981-09-15
MX3609E (es) 1981-03-31
FR2313036A1 (fr) 1976-12-31
NL188693C (nl) 1992-09-01
NL7605856A (nl) 1976-12-07
SE7606318L (sv) 1976-12-06
AU1460176A (en) 1977-12-08
JPS6210233B2 (en, 2012) 1987-03-05
JPS61246181A (ja) 1986-11-01
FR2313036B1 (en, 2012) 1979-06-29
ATA413676A (de) 1980-06-15
JPS6261593B2 (en, 2012) 1987-12-22
JPS527954A (en) 1977-01-21
LU75076A1 (en, 2012) 1977-03-07
DK152675B (da) 1988-04-11
SE445112B (sv) 1986-06-02
DK152675C (da) 1988-10-31
AU517489B2 (en) 1981-08-06
JPS6261592B2 (en, 2012) 1987-12-22
IL49716A0 (en) 1976-08-31
IE43849L (en) 1976-12-05
DE2524955C3 (de) 1981-12-03
SE7910057L (sv) 1979-12-06
IE43849B1 (en) 1981-06-17
US4258053A (en) 1981-03-24

Similar Documents

Publication Publication Date Title
AT347922B (de) Verfahren zur herstellung von neuen benzoesaeuren, deren estern und salzen
AT356091B (de) Verfahren zur herstellung von neuen heterocyclisch substituierten 5-sulfamoyl- benzoesaeurederivaten und ihren salzen
ATA942975A (de) Verfahren zur herstellung von neuen 1-substituierten-4-benzylidenpiperidene und ihren salzen
AT360024B (de) Verfahren zur herstellung von neuen pyrimid-4- on- und-thion-derivaten und ihren salzen mit saeuren
AT365185B (de) Verfahren zur herstellung von neuen 1benzazolylalkylpiperidinen und ihren salzen mit saeuren
AT342772B (de) Verfahren zur herstellung von neuen adriamycinestern
ATA702976A (de) Verfahren zur herstellung von neuen n-aryl-n- (4-piperidinyl)-arylacetamiden und ihren salzen
AT359486B (de) Verfahren zur herstellung von neuen thiophen- derivaten und ihren salzen
AT348518B (de) Verfahren zur herstellung von neuen 2-thiol- 4,5-diphenyloxazol-s-derivaten und ihren salzen
AT353257B (de) Verfahren zur herstellung von neuen dibenzo- furanderivaten und ihren salzen
ATA602576A (de) Verfahren zur herstellung von neuen tert- -butylaminopropoxy-indolen und ihren saeure- additionssalzen
AT343118B (de) Verfahren zur herstellung von neuen thienotriazolodiazepin-derivaten und ihren salzen
ATA307175A (de) Verfahren zur herstellung von neuen prostansaeurederivaten und von ihren salzen
ATA606175A (de) Verfahren zur herstellung von neuen prostansaeurederivaten und von ihren salzen
ATA385775A (de) Verfahren zur herstellung von neuen thiophenderivaten und ihren salzen
AT360671B (de) Verfahren zur herstellung von neuen thienyl- -prostaglandinen, ihren salzen und estern
AT342034B (de) Verfahren zur herstellung von neuen 4,4-diphenyl-2-hydroxybutylaminen und ihren salzen
AT358030B (de) Verfahren zur herstellung von neuen thiazolidinderivaten und ihren salzen
AT342049B (de) Verfahren zur herstellung von neuen 4-oxo-4h-pyrano- (3,2-c)-chinolin-2-carbonsauren und ihren salzen
ATA385675A (de) Verfahren zur herstellung von neuen thiophenderivaten und ihren salzen
AT341529B (de) Verfahren zur herstellung von neuen azatetracyclen und ihren salzen
AT336787B (de) Verfahren zur herstellung von neuen cephemderivaten sowie ihren estern und salzen
AT355569B (de) Verfahren zur herstellung von neuen, substi- tuierten pyridoindolen und ihren salzen
AT358027B (de) Verfahren zur herstellung von neuen indol- derivaten und ihren salzen
AT358013B (de) Verfahren zur herstellung von neuen aryloxy- alkyl-p-aminobenzoesaeuren, deren salzen und estern

Legal Events

Date Code Title Description
ELA Expired due to lapse of time
ELJ Ceased due to non-payment of the annual fee